2289 — Charmacy Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$592.92m
- HK$1.51bn
- CNY4.38bn
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17
Brief: Charmacy Pharmaceutical Says Trading In Shares Of Co On Stock Exchange Of Hong Kong Will Be Halted
Brief: Charmacy Pharmaceutical Sees Net Profit Attributable For 11 Months Of RMB32 Million
Brief: Charmacy Pharmaceutical Agreed To Surrender Land In Chancheng District
Brief: Charmacy Pharmaceutical Says Informed On 13 Sept Chairman Sold 9% Stake Of Co
Brief: Charmacy Pharmaceutical Says Trading In Shares Of Co On Stock Exchange Of HK To Be Halted
Brief: Charmacy Pharmaceutical Says HY Net Profit Attributable Down 20.50%
Brief: Charmacy Pharmaceutical Announces Proposed Appointment Of Zhang Hanzi As Executive Director
Brief: Charmacy Pharmaceutical Announces Stock Exchange Approval For Listing Of 80 Mln H Shares
Brief: Charmacy Pharmaceutical Says Formal Approval From CSRC Received
Brief: Charmacy Pharmaceutical Co Says Co & Individual Entered Into Framework Sales Agreement & Framework Purchases Agreement
Brief: Charmacy Pharmaceutical Says Lin Zhixiong Resigns As Executive Director, CFO
Brief: Charmacy Pharmaceutical Sees Decrease Of 38% To 48% In Net Profit Attributable For Year
Brief: Charmacy Pharmaceutical Submits Application For Conversion Of All Domestic Shares Into H Shares
Brief: Charmacy Pharmaceutical Says Shareholders To Transfer 29.1 Mln Domestic Shares To Jiangzhong Pharmaceutical
Brief: Charmacy Pharmaceutical Updates On Possible Transaction